Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
ABSTRACT Objectives: Randomised controlled trials that directly compare cholinesterase inhibitors for the treatment of Alzheimer's disease have been characterised by significant methodological limitations. As a consequence, they have failed to establish whether there are differences between age...
Gespeichert in:
Veröffentlicht in: | Current medical research and opinion 2005-08, Vol.21 (8), p.1317-1327 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!